title: Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
authors.affiliation: From the Division of Neuro-oncology (M.M.), Virginia Commonwealth University (I.A.), Richmond. iyad.alnahhas@gmail.com.
authors.forename: Iyad
authors.initials: I
authors.lastname: Alnahhas
authors.affiliation: From the Division of Neuro-oncology (M.M.), Virginia Commonwealth University (I.A.), Richmond.
authors.forename: Mark
authors.initials: M
authors.lastname: Malkin
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D001921:Brain / Q000187:drug effects / Q000528:radiation effects*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000379:methods*; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D008727:Methotrexate